Mainz Biomed N.V. (NASDAQ:QUCY) — Market Cap & Net Worth

$5.14 Million USD · Rank #28312

Market Cap & Net Worth: Mainz Biomed N.V. (QUCY)

Mainz Biomed N.V. (NASDAQ:QUCY) has a market capitalization of $5.14 Million ($5.14 Million) as of May 2, 2026. Listed on the NASDAQ stock exchange, this USA-based company holds position #28312 globally and #5576 in its home market, demonstrating a -19.47% decrease in market value over the past year.

Market capitalization, also known as net worth in stock markets, is calculated by multiplying Mainz Biomed N.V.'s stock price $0.41 by its total outstanding shares 12515336 (12.52 Million). Analyse Mainz Biomed N.V. operating cash flow efficiency to see how efficiently the company converts income to cash.

Mainz Biomed N.V. Market Cap History: 2026 to 2026

Mainz Biomed N.V.'s market capitalization history from 2026 to 2026. Data shows growth from $5.14 Million to $5.14 Million (0.00% CAGR).

Mainz Biomed N.V. Market Cap to Earnings & Revenue Ratios Timeline

This chart shows how Mainz Biomed N.V.'s valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance.

Latest Price to Sales (P/S) Ratio

No P/S ratio data available

Latest Price to Earnings (P/E) Ratio

No P/E ratio data available

What These Ratios Tell Investors:

Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
Industry comparison provides context for whether the company is valued higher or lower than peers.

Year	Market Cap (USD)	Revenue (USD)	Net Income (USD)	P/S Ratio	P/E Ratio
No financial ratio data available

Competitor Companies of QUCY by Market Capitalization

Companies near Mainz Biomed N.V. in the global market cap rankings as of May 2, 2026.

Key companies related to Mainz Biomed N.V. by market ranking:

Thermo Fisher Scientific Inc (NYSE:TMO): Ranked #126 globally with a market cap of $176.29 Billion USD.
Danaher Corporation (NYSE:DHR): Ranked #189 globally with a market cap of $123.72 Billion USD.
IDEXX Laboratories Inc (NASDAQ:IDXX): Ranked #578 globally with a market cap of $45.31 Billion USD.
LONZA GROUP UNSP.ADR 1/10 (F:LO3A): Ranked #643 globally with a market cap of $41.04 Billion USD ( €35.10 Billion EUR).

Market capitalization comparison (in billions USD)

Rank	Company	Symbol	Market Cap	Price
#126	Thermo Fisher Scientific Inc	NYSE:TMO	$176.29 Billion	$469.21
#189	Danaher Corporation	NYSE:DHR	$123.72 Billion	$175.15
#578	IDEXX Laboratories Inc	NASDAQ:IDXX	$45.31 Billion	$567.46
#643	LONZA GROUP UNSP.ADR 1/10	F:LO3A	$41.04 Billion	€54.50

Mainz Biomed N.V. Historical Marketcap From 2026 to 2026

Between 2026 and today, Mainz Biomed N.V.'s market cap moved from $5.14 Million to $ 5.14 Million, with a yearly change of 0.00%.

Year	Market Cap	Change (%)
2026	$5.14 Million	--

End of Day Market Cap According to Different Sources

On May 2nd, 2026 the market cap of Mainz Biomed N.V. was reported to be:

Source	Market Cap
Yahoo Finance	$5.14 Million USD
MoneyControl	$5.14 Million USD
MarketWatch	$5.14 Million USD
marketcap.company	$5.14 Million USD
Reuters	$5.14 Million USD

Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.

About Mainz Biomed N.V.

NASDAQ:QUCY USA Diagnostics & Research

Market Cap

$5.14 Million

Market Cap Rank

#28312 Global

#5576 in USA

Share Price

$0.41

Change (1 day)

-3.73%

52-Week Range

$0.41 - $0.61

All Time High

$0.61